All Regulatory Rapporteur articles in November 2025
View all stories from this issue.
-
EditorialTOPRA Symposium 2025: Leading with impact
This issue reports on the human medicine, medical device, IVD and veterinary medicine sessions from the 2025 TOPRA Symposium.
-
ContentsRegulatory Rapporteur November 2025 – Contents
The November issue of Regulatory Rapporteur reports on sessions from the TOPRA Symposium 2025.
-
ContentsNovember 2025 – Contents: Human medicines sessions
The November issue of Regulatory Rapporteur reports on the human medicines sessions from the TOPRA Symposium 2025.
-
ContentsNovember 2025 – Contents: Medical devices/IVD sessions
The November issue of Regulatory Rapporteur reports on the medical devices/IVD sessions from the TOPRA Symposium 2025.
-
ContentsNovember 2025 – Contents: Veterinary medicines sessions
The November issue of Regulatory Rapporteur reports on the veterinary medicines sessions from the TOPRA Symposium 2025.
-
JournalHM1: General pharmaceutical legislation - Platform technology and sandbox approaches
This is a report of the HM1 session that took place at this year’s Symposium.
-
JournalHM2: Fireside chat
This is a report of the HM2 session that took place at this year’s Symposium.
-
JournalHM3: Applying Artificial Intelligence in real life
This is a report of the HM3 session that took place at this year’s Symposium.
-
JournalHM9: From barrier to bridge – Practical strategies for successful advanced therapy medicinal product (ATMP) development
This is a report of the HM9 session that took place at this year’s Symposium.
-
JournalPS1: Tailored development of biosimilars without efficacy and safety studies – Is this the future?
This is a report of the PS1 session that took place at this year’s Symposium.
-
JournalHM10: Strengthening Europe’s clinical trials competitiveness
This is a report of the HM10 session that took place at this year’s Symposium.
-
JournalPS2: Navigating the green horizon – Environmental sustainability and regulatory affairs
This is a report of the PS2 session that took place at this year’s Symposium.
-
JournalMD5: The evolution of the EU Medical Device Regulation
This is a report of the MD5 session that took place at this year’s Symposium.
-
JournalMD6: The importance of digital health – Digital Health Applications (DiGA) and the Digital Mental Health Technology Project
This is a report of the MD6 session that took place at this year’s Symposium.
-
JournalMD7: Updates on Artificial Intelligence legislation and policy
This is a report of the MD7 session that took place at this year’s Symposium.
-
JournalMD8: Post-market challenges for medical devices
This is a report of the MD8 session that took place at this year’s Symposium.
-
JournalIVD5: Navigating conformity assessment for IVDs – Challenges and opportunities
This is a report of the HM5/MD1/IVD1 session that took place at this year’s Symposium.
-
JournalIVD6: The evolution of the In Vitro Diagnostic Regulation
This is a report of the IVD6 session that took place at this year’s Symposium.
-
JournalIVD7: EU reference laboratories under the IVDR – One year on
This is a report of the IVD7 session that took place at this year’s Symposium.
-
JournalIVD8: The hunt for evidence – An IVD perspective
This is a report of the IVD8 session that took place at this year’s Symposium.